Company Description
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.
It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications.
It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories.
The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers.
Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
| Country | United States |
| Founded | 1952 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 7,700 |
| CEO | Norman Schwartz |
Contact Details
Address: 1000 Alfred Nobel Drive Hercules, California 94547 United States | |
| Phone | 510 724 7000 |
| Website | bio-rad.com |
Stock Details
| Ticker Symbol | BIO |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000012208 |
| CUSIP Number | 090572207 |
| ISIN Number | US0905722072 |
| Employer ID | 94-1381833 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Norman D. Schwartz | Chairman and Chief Executive Officer |
| Jonathan P. DiVincenzo | President and Chief Operating Officer |
| Roop K. Lakkaraju CPA | Executive Vice President and Chief Financial Officer |
| Michael Crowley | Executive Vice President of Global Commercial Operations |
| Anette Engelhardt | Executive Vice President and President of the Clinical Diagnostics Group |
| Yong Chung | Vice President of Investor Relations |
| Matthew Werner | Senior Vice President and Chief Compliance and Privacy Officer |
| Courtney C. Enloe | Executive Vice President, General Counsel and Secretary |
| Colleen Corey | Executive Vice President of Global Human Resources |
| Lee Boyd | Senior Vice President of Global Commercial Operations - Asia Pacific |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 30, 2025 | 8-K | Current Report |
| May 20, 2025 | SD | Form - SD |
| May 5, 2025 | SCHEDULE 13G/A | Filing |
| May 5, 2025 | SCHEDULE 13G | Filing |
| May 1, 2025 | 10-Q | Quarterly Report |
| May 1, 2025 | 8-K | Current Report |
| Apr 25, 2025 | 8-K | Current Report |
| Mar 26, 2025 | ARS | Filing |
| Mar 26, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 13, 2025 | 144 | Filing |